Two studies appearing in JAMA Neurology respectively examined how variants linked to Alzheimer's disease and Parkinson's disease contribute to the conditions.
Lawsuits are being used to intimidate some scientists, writes one researcher at the New York Times.
LifeOmic, founded less than a year ago, expects omic data sets to become as clinically relevant as diagnostic medical imaging.
With its inaugural informatics director set to begin next month, the year-old IU Precision Health Initiative should begin its research work this fall.
A culture change is needed to make science more reproducible, says Indiana's Aaron Carroll at the New York Times.
A chromosome 15 variant may have ties to congenital heart failure in breast cancer patients who receive treatment with the anthracycline chemotherapy doxorubicin.
Indiana University researchers said that insights into this mechanism could lead to finding treatment targets for both diseases.
The method works by adding noise to database search results to confound algorithms that try to access private details about contributing individuals.
The results support a survival benefit for patients treated with therapies guided by combined DNA and mRNA sequencing and protein expression analyses.
The initiative is being funded under the university's Grand Challenges Program, which aims to promote research that will benefit communities across the state.
American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.
A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.
Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.
In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.